ESYT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.461620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.653500E-02
Normal-vs-Stage2
1.206800E-01
Normal-vs-Stage3
7.345800E-01
Normal-vs-Stage4
1.980800E-01
Stage1-vs-Stage2
7.464200E-02
Stage1-vs-Stage3
2.733400E-01
Stage1-vs-Stage4
4.331000E-01
Stage2-vs-Stage3
1.424230E-01
Stage2-vs-Stage4
6.368800E-01
Stage3-vs-Stage4
2.248000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.447380E-01
Normal-vs-AfricanAmerican
1.105810E-01
Normal-vs-Asian
4.136600E-01
Caucasian-vs-AfricanAmerican
5.126200E-01
Caucasian-vs-Asian
6.357200E-01
AfricanAmerican-vs-Asian
5.174600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.527210E-01
Normal-vs-Female
1.487800E-01
Male-vs-Female
6.750000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.965800E-01
Normal-vs-Age(41-60Yrs)
4.503600E-02
Normal-vs-Age(61-80Yrs)
2.173000E-01
Normal-vs-Age(81-100Yrs)
3.323600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.694030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.234400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.127400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.202800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.240500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.377400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.389200E-01
Normal-vs-Daily Drinker
2.315600E-01
Normal-vs-Weekly Drinker
1.776960E-01
Normal-vs-Occasional Drinker
8.091500E-02
Normal-vs-Social Drinker
5.760400E-02
Non Drinker-vs-Daily Drinker
9.916800E-01
Non Drinker-vs-Weekly Drinker
7.729400E-01
Non Drinker-vs-Occasional Drinker
3.618200E-01
Non Drinker-vs-Social Drinker
4.303200E-01
Daily Drinker-vs-Weekly Drinker
7.348000E-01
Daily Drinker-vs-Occasional Drinker
3.021000E-01
Daily Drinker-vs-Social Drinker
3.538200E-01
Weekly Drinker-vs-Occasional Drinker
5.506000E-01
Weekly Drinker-vs-Social Drinker
6.049200E-01
Occasional Drinker-vs-Social Drinker
9.201200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.965600E-01
Normal-vs-Grade 2
1.050190E-01
Normal-vs-Grade 3
1.442390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.259870E-02
Grade 1-vs-Grade 3
6.739400E-03
Grade 1-vs-Grade 4
4.965600E-01
Grade 2-vs-Grade 3
2.016800E-01
Grade 2-vs-Grade 4
1.050190E-01
Grade 3-vs-Grade 4
1.442390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.295800E-01
Normal-vs-NonDiabetic
1.496440E-01
Diabetic-vs-NonDiabetic
5.121200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.404100E-02
Normal-vs-NoPancreatitis
1.788630E-01
Pancreatitis-vs-NoPancreatitis
5.281400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.894610E-01
Normal-vs-N1
1.331440E-01
N0-vs-N1
2.283200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.492300E-02
Normal-vs-TP53-NonMutant
2.863800E-01
TP53-Mutant-vs-TP53-NonMutant
2.602500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
